FTRE
Price
$17.69
Change
-$0.12 (-0.67%)
Updated
Jan 17 closing price
Capitalization
1.59B
57 days until earnings call
RIGL
Price
$20.13
Change
+$2.78 (+16.02%)
Updated
Jan 17 closing price
Capitalization
354.59M
Ad is loading...

FTRE vs RIGL

Header iconFTRE vs RIGL Comparison
Open Charts FTRE vs RIGLBanner chart's image
Fortrea Holdings
Price$17.69
Change-$0.12 (-0.67%)
Volume$497.59K
Capitalization1.59B
Rigel Pharmaceuticals
Price$20.13
Change+$2.78 (+16.02%)
Volume$584.55K
Capitalization354.59M
FTRE vs RIGL Comparison Chart
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. RIGL commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Hold and RIGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (FTRE: $17.69 vs. RIGL: $20.13)
Brand notoriety: FTRE and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 46% vs. RIGL: 210%
Market capitalization -- FTRE: $1.59B vs. RIGL: $354.59M
FTRE [@Biotechnology] is valued at $1.59B. RIGL’s [@Biotechnology] market capitalization is $354.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both FTRE and RIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 1 TA indicator(s) are bullish while RIGL’s TA Score has 3 bullish TA indicator(s).

  • FTRE’s TA Score: 1 bullish, 6 bearish.
  • RIGL’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а -2.75% price change this week, while RIGL (@Biotechnology) price change was +23.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

FTRE is expected to report earnings on Mar 17, 2025.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($1.59B) has a higher market cap than RIGL($355M). RIGL YTD gains are higher at: 19.679 vs. FTRE (-5.147). RIGL has higher annual earnings (EBITDA): 13.7M vs. FTRE (7.1M). FTRE has more cash in the bank: 105M vs. RIGL (61.1M). RIGL has less debt than FTRE: RIGL (60.2M) vs FTRE (1.2B). FTRE has higher revenues than RIGL: FTRE (2.98B) vs RIGL (157M).
FTRERIGLFTRE / RIGL
Capitalization1.59B355M447%
EBITDA7.1M13.7M52%
Gain YTD-5.14719.679-26%
P/E RatioN/A74.56-
Revenue2.98B157M1,896%
Total Cash105M61.1M172%
Total Debt1.2B60.2M2,000%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTRERIGL
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 11 days ago
79%
Momentum
ODDS (%)
Bearish Trend 11 days ago
77%
Bearish Trend 11 days ago
87%
MACD
ODDS (%)
Bearish Trend 11 days ago
62%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
75%
Bearish Trend 11 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
72%
Bearish Trend 11 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
71%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
Bearish Trend 20 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
89%
View a ticker or compare two or three
Ad is loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JACTX52.660.56
+1.07%
Janus Henderson Forty T
JRGRX29.230.31
+1.07%
JHancock Regional Bank R6
TQGEX18.270.14
+0.77%
T. Rowe Price Integrated Global Eq
BSGPX12.390.07
+0.57%
Baillie Gifford Developed EAFE All Cap I
GEMSX20.640.07
+0.34%
Goldman Sachs Emerging Markets Eq Svc

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with RVNC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then RVNC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-0.67%
RVNC - FTRE
34%
Loosely correlated
+12.54%
TECH - FTRE
33%
Loosely correlated
-0.35%
RIGL - FTRE
33%
Poorly correlated
+16.02%
CORT - FTRE
32%
Poorly correlated
+1.60%
MGTX - FTRE
31%
Poorly correlated
+5.56%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with AVXL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+16.02%
AVXL - RIGL
39%
Loosely correlated
-9.26%
NTLA - RIGL
38%
Loosely correlated
+0.85%
WVE - RIGL
38%
Loosely correlated
-2.83%
RCUS - RIGL
37%
Loosely correlated
-0.64%
KYMR - RIGL
37%
Loosely correlated
+0.79%
More